Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib
Completed · Phase 2
Conditions studied: Tumor Pathway Activations Inhibited by Dovitinib
In brief
The purpose of this signal seeking study was to determine whether treatment with dovitinib (TKI258) demonstrated sufficient efficacy in select pathway-activated solid tumors and/or hematologic malignancies to warrant further study.
Key facts
- Study ID
- NCT01831726
- Run by
- Novartis Pharmaceuticals
- People needed
- 80
- Starts
- 2013-08-01
- Expected to finish
- 2015-12-01
- Last updated by the study team
- 2017-03-20
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Alabama Oncology — Birmingham, Alabama, United States
- Highlands Oncology Group SC — Fayetteville, Arkansas, United States
- PCR Oncology — Pismo Beach, California, United States
- Sarcoma Oncology Center — Santa Monica, California, United States
- Rocky Mountain Cancer Centers Rocky Mountain Cancer Centers — Greenwood Village, Colorado, United States
- Whittingham Cancer Center Norwalk Hospital — Norwalk, Connecticut, United States
- Memorial Cancer Institute Memorial Healthcare System — Hollywod, Florida, United States
- Cancer Specialists of North Florida Cancer Specialists (2) — Jacksonville, Florida, United States
- Florida Hospital Cancer Institute — Orlando, Florida, United States
- Space Coast Medical Associates Space Coast Cancer Center — Titusville, Florida, United States
- University Cancer & Blood Center, LLC — Athens, Georgia, United States
- NorthWest Georgia Oncology Centers NW Georgia Oncology — Marietta, Georgia, United States
- Lurie Children's Hospital of Chicago Developmental Therapeutics — Chicago, Illinois, United States
- Illinois Cancer Care — Peoria, Illinois, United States
- Indiana University Indiana Univ. - Purdue Univ. — Indianapolis, Indiana, United States
- Horizon Oncology Center Horizon Oncology Ctr. — Lafayette, Indiana, United States
- St. Agnes Hospital St. Agnes Hospital (2) — Baltimore, Maryland, United States
- University of Michigan Int. Medicine Oncology — Ann Arbor, Michigan, United States
- Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology — Minneapolis, Minnesota, United States
- Billings Clinic Onc Dept — Billings, Montana, United States
- Southeast Nebraska Oncology Cancer Center — Lincoln, Nebraska, United States
- Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) — Las Vegas, Nevada, United States
- Waverly Hematology Oncology — Cary, North Carolina, United States
- Oncology Hematology Care, Inc. Oncology Hematology Care (2) — Cincinnati, Ohio, United States
- Cleveland Clinic Foundation Cleveland Clinic (19) — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.